Viscogliosi Brothers Acquisition Corp (Nasdaq: VBOC) is a blank-check company sponsored by Viscogliosi Brothers, LLC, a firm with deep roots in musculoskeletal healthcare and medical device investing. The SPAC completed its initial public offering in 2022 and is focused on identifying a target in the healthcare sector, with a particular emphasis on orthopedics and related life sciences industries. The company filed its Form 10-Q on May 12, 2023, covering the quarterly period ended March 31, 2023, reflecting its ongoing search for a business combination target. As of the filing date, no definitive merger agreement had been announced. Sign up for SpacDesk to access full filings, deal timelines, and sponsor intelligence on VBOC and hundreds of other active SPACs.